Brain Health at the Institute for Personalized Medicine
At the Institute for Personalized Medicine, we offer an advanced brain health protocol, crafted from my extensive experience working alongside Dr. Dale Bredesen, a pioneering researcher in Alzheimer’s prevention and cognitive health. While inspired by the principles of the Bredesen Protocol, our approach is uniquely tailored to delve deeply into the root causes of neurodegeneration, aiming to support and restore brain function in a safe and effective way. This multi-modal protocol combines rigorously researched lifestyle modifications with optimized blood biomarker analysis, utilizing a blend of targeted nutraceuticals and nootropics to foster cognitive resilience and vitality. Each component of our program is backed by evidence, including insights from the influential Lancet Commission report on Alzheimer’s disease prevention, which highlights modifiable risk factors as key to reducing dementia rates.
Additional Information
Click on the items below for a brief introduction to the title subject and links to the complete reference.
Reversal of cognitive decline: A novel therapeutic program
Abstract Cognitive decline is a major concern of the aging population, and Alzheimer’s disease is the major cause of age-related cognitive...
Inhalational Alzheimer’s disease: An unrecognized—and treatable—epidemic
Abstract Alzheimer’s disease is now the third leading cause of death in the United States, following only cardiovascular disease and...
Metabolic profiling distinguishes three subtypes of Alzheimer’s disease
Abstract Alzheimer’s disease represents a major healthcare problem, with over five million Americans estimated to suffer from this...
Another Role for ApoE?
Abstract Key Alzheimer’s disease-related protein may be a transcriptional regulator. The allele apolipoprotein E c4 (APOE £4) is...
Direct Transcriptional Effects of Apolipoprotein E
Abstract A major unanswered question in biology and medicine is the mechanism by which the product of the apolipoprotein E ! 4 allele,...
Prionic Loops, Anti-Prions, and Dependence Receptors in Neurodegeneration
Abstract Stan had discovered and coined the term prions in 1982, and when I established my own laboratory in 1989, I wanted to address two...
Next generation therapeutics for Alzheimer’s disease
Abstract To date, no truly effective therapy has been developed for Alzheimer’s disease or mild cognitive impairment. In searching for new...
Reversal of Cognitive Decline in Alzheimer’s Disease
Abstract Alzheimer’s disease is one of the most significant healthcare problems nationally and globally. Recently, the first description...